Foodborne Diseases Treatment Market: By Drug Class, By Disease, By Route of Administration, By Distribution Channel and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Foodborne Diseases Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Class (Antibiotics, Anti Diarrhea, Fluids and Electrolyte Replenishers, Vaccines, Others), By Disease (Botulism, Traveler's Diarrhea, Gastroenteritis, Toxoplasmosis, Others), By Route of Administration (Parenteral, Oral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Foodborne diseases treatment market size was valued at US$ 9281.2 million in 2023, and is poised to grow at a CAGR of 7.5% during the forecast year 2024-2030. The foodborne diseases treatment market refers to the healthcare sector focused on diagnosing and treating illnesses and infections caused by the consumption of contaminated or unsafe food. Foodborne diseases, often referred to as food poisoning, can result from the ingestion of bacteria, viruses, parasites, or chemical substances that contaminate food or water. Common pathogens associated with foodborne diseases include Salmonella, E. coli, Campylobacter, Norovirus, and Listeria, among others. These diseases are due to the intake of food contaminated with harmful microorganisms or chemicals.

The contamination occurs in any way either soil, water, or air. Clinical symptoms of foodborne diseases are seen in the gastrointestinal tract. Symptoms include vomiting, diarrhea, and abdominal pain. Common foodborne diseases include botulism, salmonellosis, traveler's diarrhea, gastroenteritis, tapeworm infection, and hepatitis, among others. According to the findings of WHO Estimates of the global burden of foodborne diseases in 2015, almost 1 in every10 people fall ill yearly due to contaminated food consumption, and 420,000 deaths occur as a result. Market players are adopting drug developments and collaborations as key market strategies. 

Foodborne Diseases Treatment MarketKey Developments :Foodborne diseases treatment market

In 2015, January, Valneva SE, entered a purchase and sale with Crucell Holland B.V. to acquire Crucell Sweden AB and privileges and licenses of the dukoral vaccine to treat cholera and traveler's diarrhea.

summary download arrow Download Free Sample

Global Foodborne Diseases Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.5%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Foodborne Diseases Treatment Market Dynamics

Increase in R&D investment, growing awareness about foodborne disease symptoms due to initiatives of government and non-government organizations such as WHO, and lack of hygiene conditions are boosting the foodborne diseases treatment market worldwide. However, the high cost of R&D investment for development of anti microbial and stringent, time-consuming regulatory procedures are expected to hinder the foodborne diseases market

Global Foodborne Diseases Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 9281.2 million

Market CAGR

7.5%

By Drug Class

  •  Antibiotics,
  • Anti Diarrhea,
  • Fluids and Electrolyte Replenishers,
  • Vaccines,
  • Others

By Disease

  • Botulism,
  • Traveler's Diarrhea,
  • Gastroenteritis,
  • Toxoplasmosis,
  • Others

By Route of Administration

  • Parenteral,
  • Oral,
  • Others

By Distribution Channel

  • Hospital Pharmacies,
  • Retail Pharmacies,
  • Online Pharmacies,
  • Drug Stores

Key Features of the Report

  • The foodborne diseases treatment market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The Foodborne Diseases Treatment Market size was valued at US$ 9281.2 million in 2023, and is poised to grow at a CAGR of 7.5% during the forecast year 2024-2030.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The foodborne diseases treatment market key players are Bayer AG (Germany) Johnson & Johnson Services Inc., (U.S.) Merck & Co., Inc. (U.S.) GlaxoSmithKline plc (U.K)

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Foodborne Diseases Treatment Market Introduction 
2.1.Global Foodborne Diseases Treatment Market  - Taxonomy
2.2.Global Foodborne Diseases Treatment Market  - Definitions
2.2.1.Drug Class 
2.2.2.Disease
2.2.3. Route of Administration 
2.2.4.Distribution Channel 
2.2.5.Region
3.Global Foodborne Diseases Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Foodborne Diseases Treatment Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Foodborne Diseases Treatment Market  By Drug Class , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1.  Antibiotics,
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Anti Diarrhea,
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Fluids and Electrolyte Replenishers,
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Vaccines,
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Foodborne Diseases Treatment Market  By Disease, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Botulism,
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Traveler's Diarrhea,
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Gastroenteritis,
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Toxoplasmosis,
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Foodborne Diseases Treatment Market  By  Route of Administration , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Parenteral,
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Oral,
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Foodborne Diseases Treatment Market  By Distribution Channel , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospital Pharmacies,
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Retail Pharmacies,
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Online Pharmacies,
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Drug Stores
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Foodborne Diseases Treatment Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Foodborne Diseases Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Drug Class  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1. Antibiotics,
10.1.2.Anti Diarrhea,
10.1.3.Fluids and Electrolyte Replenishers,
10.1.4.Vaccines,
10.1.5.Others
10.2.  Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Botulism,
10.2.2.Traveler's Diarrhea,
10.2.3.Gastroenteritis,
10.2.4.Toxoplasmosis,
10.2.5.Others
10.3.   Route of Administration  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Parenteral,
10.3.2.Oral,
10.3.3.Others
10.4.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospital Pharmacies,
10.4.2.Retail Pharmacies,
10.4.3.Online Pharmacies,
10.4.4.Drug Stores
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Foodborne Diseases Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Drug Class  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1. Antibiotics,
11.1.2.Anti Diarrhea,
11.1.3.Fluids and Electrolyte Replenishers,
11.1.4.Vaccines,
11.1.5.Others
11.2.  Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Botulism,
11.2.2.Traveler's Diarrhea,
11.2.3.Gastroenteritis,
11.2.4.Toxoplasmosis,
11.2.5.Others
11.3.   Route of Administration  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Parenteral,
11.3.2.Oral,
11.3.3.Others
11.4.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospital Pharmacies,
11.4.2.Retail Pharmacies,
11.4.3.Online Pharmacies,
11.4.4.Drug Stores
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Foodborne Diseases Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Drug Class  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1. Antibiotics,
12.1.2.Anti Diarrhea,
12.1.3.Fluids and Electrolyte Replenishers,
12.1.4.Vaccines,
12.1.5.Others
12.2.  Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Botulism,
12.2.2.Traveler's Diarrhea,
12.2.3.Gastroenteritis,
12.2.4.Toxoplasmosis,
12.2.5.Others
12.3.   Route of Administration  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Parenteral,
12.3.2.Oral,
12.3.3.Others
12.4.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospital Pharmacies,
12.4.2.Retail Pharmacies,
12.4.3.Online Pharmacies,
12.4.4.Drug Stores
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Foodborne Diseases Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Drug Class  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1. Antibiotics,
13.1.2.Anti Diarrhea,
13.1.3.Fluids and Electrolyte Replenishers,
13.1.4.Vaccines,
13.1.5.Others
13.2.  Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Botulism,
13.2.2.Traveler's Diarrhea,
13.2.3.Gastroenteritis,
13.2.4.Toxoplasmosis,
13.2.5.Others
13.3.   Route of Administration  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Parenteral,
13.3.2.Oral,
13.3.3.Others
13.4.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospital Pharmacies,
13.4.2.Retail Pharmacies,
13.4.3.Online Pharmacies,
13.4.4.Drug Stores
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Foodborne Diseases Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Drug Class  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1. Antibiotics,
14.1.2.Anti Diarrhea,
14.1.3.Fluids and Electrolyte Replenishers,
14.1.4.Vaccines,
14.1.5.Others
14.2.  Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Botulism,
14.2.2.Traveler's Diarrhea,
14.2.3.Gastroenteritis,
14.2.4.Toxoplasmosis,
14.2.5.Others
14.3.   Route of Administration  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Parenteral,
14.3.2.Oral,
14.3.3.Others
14.4.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospital Pharmacies,
14.4.2.Retail Pharmacies,
14.4.3.Online Pharmacies,
14.4.4.Drug Stores
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Bayer AG (Germany)
15.2.2.Johnson & Johnson Services Inc., (U.S.)
15.2.3.Merck & Co., Inc. (U.S.)
15.2.4.GlaxoSmithKline plc (U.K)
15.2.5.Novartis AG (Switzerland
15.2.6.XOMA Corporation (U.S.)
15.2.7.AlphaVax, Inc. (U.S.)
15.2.8.Molecular Targeting Technologies, Inc. (U.S.),
15.2.9.Morphotek Inc. (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Bayer AG (Germany)
  • Johnson & Johnson Services Inc., (U.S.)
  • Merck & Co., Inc. (U.S.)
  • GlaxoSmithKline plc (U.K)
  • Novartis AG (Switzerland
  • XOMA Corporation (U.S.)
  • AlphaVax, Inc. (U.S.)
  • Molecular Targeting Technologies, Inc. (U.S.),
  • Morphotek Inc. (U.S.)

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market